Thank you for agreeing to participate in this survey.

You have been chosen for this Conditional License Program because we respect your opinion and expertise in the field of veterinary dermatology. Your valuable feedback will help us gather important clinical information and allow us to be better prepared when we launch this new biotherapeutic to the entire veterinary community.

Once you have administered Canine Atopic Dermatitis Immunotherapeutic* to several patients, please provide us with feedback about your experience below.

ALL FIELDS IN BOLD ARE REQUIRED.

CONTACT INFORMATION



PRODUCT INFORMATION

Did you prescribe Canine Atopic Dermatitis Immunotherapeutic* concurrently with any other product to treat atopic dermatitis?

   

If yes, what products? (Check all that apply.)


Based on your recent experience with Canine Atopic Dermatitis Immunotherapeutic,* do you intend to prescribe the product in the next six months?

   

If you chose Canine Atopic Dermatitis Immunotherapeutic* instead of other therapeutic options to treat clinical signs associated with atopic dermatitis, which product(s) or category are you likely to replace? (Check all that apply.)

What is your overall satisfaction with the efficacy of Canine Atopic Dermatitis Immunotherapeutic?*

What is your overall satisfaction with the speed of onset of Canine Atopic Dermatitis Immunotherapeutic?*

  • Satisfied
  • Very dissatisfied

Would you recommend this product to fellow veterinarians?

Please indicate your level of agreement/disagreement with the following statements:
By aiding in the reduction of the clinical signs associated with atopic dermatitis, this product has improved the quality of life for the DOGS for which it was prescribed.

  • Strongly agree
  • Agree
  • Neither agree nor disagree
  • Disagree
  • Strongly disagree

By aiding in the reduction of the clinical signs associated with atopic dermatitis, this product has improved the quality of life for OWNERS of the dogs for which it was prescribed.

What do you see as the single, primary benefit of Canine Atopic Dermatitis Immunotherapeutic?* (Select one.)

What do you see as the secondary benefits of Canine Atopic Dermatitis Immunotherapeutic?* (Select any that you find important.)


Report all adverse events (side effects) within 24 hours by
calling 1-888-ZOETIS1 (888-963-8471) or by
emailing VMIPSrecords@zoetis.com.